Disc Medicine, Inc.
IRON
$42.17
$1.172.84%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -109.36M | -103.48M | -91.00M | -80.60M | -76.43M |
| Total Depreciation and Amortization | 156.00K | 172.00K | 186.00K | 101.00K | 100.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.04M | 10.21M | 9.70M | 8.91M | 5.82M |
| Change in Net Operating Assets | 3.23M | 8.95M | 6.85M | -11.00K | -2.95M |
| Cash from Operations | -93.93M | -84.15M | -74.26M | -71.60M | -73.46M |
| Capital Expenditure | -505.00K | -59.00K | -112.00K | -127.00K | -89.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -291.83M | -290.85M | -219.75M | -- | -- |
| Cash from Investing | -292.33M | -290.91M | -219.86M | -127.00K | -89.00K |
| Total Debt Issued | 28.99M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 190.72M | 197.28M | 197.37M | 168.66M | 201.80M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.39M | 0.00 | -58.00K | 9.32M | 37.58M |
| Cash from Financing | 218.31M | 197.28M | 197.31M | 177.97M | 239.38M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -167.94M | -177.78M | -96.82M | 106.25M | 165.83M |